Safflomide
Safflomide is a phenylpropanoid amide compound isolated from safflower (Carthamus tinctorius) seeds, structurally related to serotonin-conjugated hydroxycinnamic acid derivatives. Its primary mechanism involves upregulating adiponectin secretion from adipose tissue, which activates downstream AMPK and PPARα signaling pathways to support metabolic homeostasis.
Origin & History
Safflomide is a bioactive compound isolated from safflower (Carthamus tinctorius L.), an annual herbaceous plant cultivated throughout China and used in traditional Chinese medicine. It belongs to the class of compounds that influence adiponectin expression and is extracted from safflower, though specific extraction methods are not detailed in available sources.
Historical & Cultural Context
Safflower has been used in traditional Chinese medicine since at least 1978 for cardiovascular diseases, diabetes, and circulation issues. In Persian traditional medicine, it treats conditions ranging from inflammation and rheumatism to melancholy and poisoning.
Health Benefits
• Increases plasma adiponectin levels by over 30% in high-fat diet models (preliminary animal evidence) • May support metabolic health through adiponectin pathway activation (preliminary evidence) • Related safflower extracts show benefits for abdominal obesity and insulin resistance (moderate human evidence, PMID: 34487844) • Parent plant compounds demonstrate neuroprotective effects in Parkinson's disease models (preliminary animal evidence) • Traditional use suggests cardiovascular and anti-inflammatory support (traditional evidence only)
How It Works
Safflomide appears to stimulate adiponectin gene expression and secretion in adipocytes, with adiponectin subsequently binding AdipoR1 and AdipoR2 receptors to activate AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPARα). AMPK activation promotes fatty acid oxidation and inhibits lipogenic enzyme activity, including acetyl-CoA carboxylase (ACC), thereby reducing ectopic lipid accumulation. Additionally, PPARα upregulation enhances mitochondrial beta-oxidation and modulates inflammatory cytokine expression, contributing to improved insulin sensitivity at the cellular level.
Scientific Research
Human clinical evidence for safflomide itself is absent, with research limited to one preclinical rat study (PMID: 22428927) showing 3 mg/day increased adiponectin levels. Related safflower oil showed benefits in a 2022 RCT (PMID: 34487844, n=67) where 8 g/day for 12 weeks improved metabolic syndrome parameters.
Clinical Summary
Preclinical evidence from high-fat diet-induced rodent models demonstrates that safflomide administration increases plasma adiponectin concentrations by more than 30% compared to controls, alongside improvements in lipid profiles and glycemic markers. These findings are preliminary and derive exclusively from animal studies; no peer-reviewed randomized controlled trials in human subjects have been published specifically for isolated safflomide as of current literature. Broader research on standardized safflower extract preparations containing related phenylpropanoid amides has shown modest benefits for abdominal obesity and insulin resistance in human trials, providing indirect supportive context. Overall, the evidence base is early-stage and insufficient to establish clinical dosing recommendations or confirm efficacy in human populations.
Nutritional Profile
Safflomide is a synthetic amide derivative compound, not a whole food ingredient, and therefore does not possess a conventional macronutrient or micronutrient profile. It is characterized as a bioactive small molecule rather than a nutritional source. Key bioactive identity: Safflomide is structurally related to serotonin amide derivatives found in safflower (Carthamus tinctorius) seeds, particularly analogous to serotonin hydroxycinnamic acid amides (e.g., N-feruloylserotonin, N-(p-coumaroyl)serotonin) which occur in safflower at concentrations of approximately 0.1–1.5 mg/g dry seed weight. As a compound-category ingredient, it contains no appreciable macronutrients (protein, fat, carbohydrates), dietary fiber, or conventional micronutrients (vitamins, minerals). Bioactive concentration in formulations: typically dosed in microgram-to-milligram ranges consistent with pharmacological rather than nutritional use. Bioavailability notes: Parent safflower serotonin amide compounds demonstrate moderate oral bioavailability with lipophilic characteristics aiding membrane permeability; specific bioavailability data for Safflomide itself remains limited to preliminary animal pharmacokinetic models. The compound's primary relevance is its ability to modulate adiponectin secretion pathways (PPAR-gamma and AMPK-related signaling), placing it in the category of a bioactive modulator rather than a nutrient. No caloric contribution, vitamin content, or mineral content is applicable.
Preparation & Dosage
No clinically studied human dosages exist for safflomide. Preclinical studies used 3 mg/day orally in rats. Related safflower extracts have been studied at 25-100 mg/kg/day in animals and 8 g/day safflower oil in humans. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Berberine, Chromium, Alpha-lipoic acid, Green tea extract, Cinnamon extract
Safety & Interactions
Safflomide lacks dedicated human safety and toxicology trials, making a comprehensive adverse effect profile impossible to establish at this time. Because safflomide is derived from Carthamus tinctorius, individuals with known allergies to Asteraceae/Compositae family plants should exercise caution due to potential cross-reactivity. Theoretically, its adiponectin-enhancing and AMPK-activating properties could have additive effects when combined with antidiabetic medications such as metformin or insulin, potentially increasing hypoglycemia risk, though this interaction has not been formally studied. Pregnant and breastfeeding individuals should avoid safflomide-containing supplements due to the complete absence of safety data in these populations.